Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders
- 31 March 2010
- journal article
- editorial
- Published by Elsevier BV in Experimental Neurology
- Vol. 222 (1), 1-5
- https://doi.org/10.1016/j.expneurol.2009.12.018
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (2R01 NS034239, 2R37 NS36126, P01 NS43985, P20RR15635, P30 AI42845, PO1 NS31492)
This publication has 74 references indexed in Scilit:
- Interaction of NG2+ glial progenitors and microglia/macrophages from the injured spinal cordGlia, 2009
- Innate and Adaptive Immunity for the Pathobiology of Parkinson's DiseaseAntioxidants and Redox Signaling, 2009
- Heterogeneity of Microglial Activation in the Innate Immune Response in the BrainJournal of Neuroimmune Pharmacology, 2009
- Proteomic Studies of Nitrated Alpha-Synuclein Microglia Regulation by CD4+CD25+ T CellsJournal of Proteome Research, 2009
- Strategic approaches to developing drug treatments for ALSDrug Discovery Today, 2008
- SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS modelJCI Insight, 2008
- Nitrated Alpha-Synuclein and Microglial Neuroregulatory ActivitiesJournal of Neuroimmune Pharmacology, 2008
- Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s diseaseClinical Neuroscience Research, 2006
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Alternative activation of macrophagesNature Reviews Immunology, 2003